See All Slides - tctmd.com

Slides

Presentation TCT 2013

Perspectives on Bioresorbable Scaffolds: Establishing the Benefits of a Breakthrough Technology

Presenter: Stephan Windecker

October 31, 2013

Presentation TCT 2013

Impact of Intravascular Imaging on Interventional Therapies: Lessons learned and Future Directions

Presenter: Patrick Serruys

October 31, 2013

Presentation TCT 2013

Is Intraprocedural TEE During TAVR a Luxury or a Necessity?

Presenter: Rebecca Hahn

October 31, 2013

Presentation TCT 2013

Case 1: Aggressive Lesion Preparation With Rotational Atherectomy Prior to Scaffolding

Presenter: Robert-Jan van Geuns

October 31, 2013

Presentation TCT 2013

Does Dabigatran Increase MI in Patients with Coronary Artery Disease? Addressing the Current Controversy

Presenter: Michael Ezekowitz

October 31, 2013

Presentation TCT 2013

Optimal DAPT Duration Is Not Established: For Now Most Patients Should Stay on DAPT for at Least One Year!

Presenter: Edoardo Camenzind

October 31, 2013

Presentation TCT 2013

Cases VII and VIII: Multivessel Disease (and the Functional Syntax Score)

Presenter: Chang-Wook Nam

October 31, 2013

Presentation TCT 2013

Progress in Women Undergoing Interventional Procedures: Is the Gap Narrowing?

Presenter: Alexandra Lansky

October 31, 2013

Presentation TCT 2013

Case #5: Left Main + Ostial LAD + Ostial LCX + Ostial Ramus (Trifurcation with 4 Limb Involvement)

Presenter: Corrado Tamburino

October 31, 2013

Presentation TCT 2013

Case Presentation: BTK Intervention is a Different Animal: Implications for DCB development

Presenter: Jihad Mustapha

October 31, 2013

Advertisement

Slides

Perspectives on Bioresorbable Scaffolds: Establishing the Benefits of a Breakthrough Technology

Impact of Intravascular Imaging on Interventional Therapies: Lessons learned and Future Directions

Is Intraprocedural TEE During TAVR a Luxury or a Necessity?

Case 1: Aggressive Lesion Preparation With Rotational Atherectomy Prior to Scaffolding

Does Dabigatran Increase MI in Patients with Coronary Artery Disease? Addressing the Current Controversy

Optimal DAPT Duration Is Not Established: For Now Most Patients Should Stay on DAPT for at Least One Year!

Cases VII and VIII: Multivessel Disease (and the Functional Syntax Score)

Progress in Women Undergoing Interventional Procedures: Is the Gap Narrowing?

Case #5: Left Main + Ostial LAD + Ostial LCX + Ostial Ramus (Trifurcation with 4 Limb Involvement)

Case Presentation: BTK Intervention is a Different Animal: Implications for DCB development

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content